BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33674374)

  • 1. Description of symptom course in a telemedicine monitoring clinic for acute symptomatic COVID-19: a retrospective cohort study.
    O'Keefe JB; Tong EJ; O'Keefe GD; Tong DC
    BMJ Open; 2021 Mar; 11(3):e044154. PubMed ID: 33674374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
    Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
    JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.
    Han C; Duan C; Zhang S; Spiegel B; Shi H; Wang W; Zhang L; Lin R; Liu J; Ding Z; Hou X
    Am J Gastroenterol; 2020 Jun; 115(6):916-923. PubMed ID: 32301761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring Symptoms of COVID-19: Review of Mobile Apps.
    Schmeelk S; Davis A; Li Q; Shippey C; Utah M; Myers A; Reading Turchioe M; Masterson Creber R
    JMIR Mhealth Uhealth; 2022 Jun; 10(6):e36065. PubMed ID: 35609313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient experience of symptoms and impacts of COVID-19: a qualitative investigation with symptomatic outpatients.
    Rofail D; McGale N; Podolanczuk AJ; Rams A; Przydzial K; Sivapalasingam S; Mastey V; Marquis P
    BMJ Open; 2022 May; 12(5):e055989. PubMed ID: 35501077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to resolution of respiratory and systemic coronavirus disease 2019 symptoms in community setting.
    Dinh A; Jaulmes L; Dechartres A; Duran C; Mascitti H; Lescure X; Yordanov Y; Jourdain P; ; ; ;
    Clin Microbiol Infect; 2021 Dec; 27(12):1862.e1-1862.e4. PubMed ID: 34481989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical learnings from a virtual primary care program monitoring mild to moderate COVID-19 patients at home.
    Pimlott N; Agarwal P; McCarthy LM; Luke MJ; Hum S; Gill S; Heisey R
    Fam Pract; 2021 Sep; 38(5):549-555. PubMed ID: 33340398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.
    Mika J; Tobiasz J; Zyla J; Papiez A; Bach M; Werner A; Kozielski M; Kania M; Gruca A; Piotrowski D; Sobala-Szczygieł B; Włostowska B; Foszner P; Sikora M; Polanska J; Jaroszewicz J
    Sci Rep; 2021 Jun; 11(1):13580. PubMed ID: 34193945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19's natural course among ambulatory monitored outpatients.
    Weinbergerova B; Mayer J; Hrabovsky S; Novakova Z; Pospisil Z; Martykanova L; Hortova K; Mandelova L; Hejduk K; Chloupková R; Pospisil M; Doubkova M; Marek V; Novotna R; Dolecek M; Kubesova HM; Brat K; Parizkova R; Husa P; Mechl M; Kral Z; Lengerova M
    Sci Rep; 2021 May; 11(1):10124. PubMed ID: 33980931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
    Elliott J; Whitaker M; Bodinier B; Eales O; Riley S; Ward H; Cooke G; Darzi A; Chadeau-Hyam M; Elliott P
    PLoS Med; 2021 Sep; 18(9):e1003777. PubMed ID: 34582457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis.
    Bijur PE; Friedman BW; Baron SW; Ramasahayam A; Nerenberg R; Sharpe S; Goldstein DY; Esses D
    Am J Emerg Med; 2022 Apr; 54():274-278. PubMed ID: 35220142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.